Form D — Enlaza Therapeutics, Inc.
0001231919-25-000186 · filed Sep 11, 2025
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $15,000,000
- Total sold
- $15,000,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Enlaza Therapeutics, Inc.
- CIK
- 1852950
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2020
- Address
- 11099 NORTH TORREY PINES ROAD, STE. 280
LA JOLLA, CA 92037 - Phone
- 858-348-2180
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Sergio Duron · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
-
Sanford Madigan · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
-
Tighe Reardon · Executive OfficerLa Jolla, CA Find on LinkedIn ↗
-
Jay Lichter · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Shelley Chu · DirectorLa Jolla, CA Find on LinkedIn ↗
-
James Topper · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Marcos Milla · DirectorLa Jolla, CA Find on LinkedIn ↗
-
Stephen Squinto · DirectorLa Jolla, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗